| Synthetic cathinones (bath salts): legal status and patterns of abuse JA Fass, AD Fass, AS Garcia Annals of Pharmacotherapy 46 (3), 436-441, 2012 | 109 | 2012 |
| Synthetic cathinones (‘bath salts’): legal and health care challenges JA Gershman, AD Fass Pharmacy and Therapeutics 37 (10), 571, 2012 | 41 | 2012 |
| Evaluation of Florida physicians' knowledge and attitudes toward accessing the state prescription drug monitoring program as a prescribing tool JA Gershman, JA Gershman, AD Fass, I Popovici Pain medicine 15 (12), 2013-2019, 2014 | 27 | 2014 |
| Efficacy and safety of dipeptidyl peptidase-4 inhibitors in combination with metformin AD Fass, JA Gershman Advances in therapy 30, 337-353, 2013 | 21 | 2013 |
| Physician-assisted suicide: ongoing challenges for pharmacists J Fass, A Fass American Journal of Health-System Pharmacy 68 (9), 846-849, 2011 | 17 | 2011 |
| Efficacy and usability of intranasal glucagon for the management of hypoglycemia in patients with diabetes: a systematic review D Singh-Franco, C Moreau, AD Levin, D De La Rosa, M Johnson Clinical Therapeutics 42 (9), e177-e208, 2020 | 15 | 2020 |
| Medication safety and pharmacovigilance resources for the ambulatory care setting: enhancing patient safety JA Gershman, AD Fass Hospital pharmacy 49 (4), 363-368, 2014 | 12 | 2014 |
| Dextromethorphan abuse: a literature review JA Gershman, AD Fass Journal of Pharmacy Technology 29 (2), 66-71, 2013 | 8 | 2013 |
| Hydrocodone rescheduling amendment and pipeline products on the horizon JA Gershman, AD Fass Pharmacy and Therapeutics 37 (7), 399, 2012 | 7 | 2012 |
| Prevalence of antiobesity treatment and weight-inducing antihyperglycemic agents among patients with type 2 diabetes in the United States A Levin, N Kaur, NK Mainoo, A Perez Clinical Therapeutics 44 (3), e35-e44, 2022 | 6 | 2022 |
| A Comparison of the Use of Clinical-Guideline–Recommended Antihypertensive Regimens in Mexican American, Non-Hispanic Black, and Non-Hispanic White Adults With Type 2 Diabetes … A Perez, A Levin, N Alam The Diabetes Educator 42 (6), 739-747, 2016 | 6 | 2016 |
| Call to action: The pharmacist’s role in improving contraceptive knowledge and access A Levin, K Berger Journal of the American Pharmacists Association 63 (1), 43-45, 2023 | 2 | 2023 |
| The Interprofessional Diabetes and Education Awareness (IDEA) community program SB Dunbar, HA Feldman, TM Nelson, P Vargas, L Fritzinger-Hearn, ... Journal of Interprofessional Education & Practice 7, 75-77, 2017 | 1 | 2017 |
| PCR154 Prevalence Use Trends of Hmg COA Reductase Inhibitors (STATIN) Among Adults with Type 2 Diabetes: National Health and Nutrition Examination Survey (NHANES) 2017–2020 in … Y Alharbi, A Alwadai, A Alsharif, A Levin, A Perez Value in Health 26 (6), S340, 2023 | | 2023 |
| [Chapter 3] Economic Analyses in Diabetes and Diabetes Treatment A Perez, A Wertheimer, A Levin ECONiX Research OU, 2023 | | 2023 |
| Student Learning Outcomes of an Interdisciplinary Team-Based Experience: The Interprofessional Diabetes Education and Awareness (IDEA) Initiative J Hinckley, T Morrow Nelson, M Abdou, D Broussard, J Castro, S Diaz, ... | | 2023 |
| Nonmedical Prescription Drug Use among Pharmacy and Osteopathic Medicine Students: Perceptions, Attitudes and Knowledge SE Rabionet, J Sánchez, I Popovici, AD Fass, A Perez Rivera, C Millar | | 2022 |
| Lipid-Lowering Drug Therapy Use in Patients with Type 2 Diabetes amongst Whites, Blacks, and Mexican Americans S Tunnicliffe, A Perez Rivera, A Levin | | 2022 |
| Prevalence of Antiobesity Treatment and Weight Gain Inducing Antihyperglycemics among Patients with Type 2 Diabetes in the United States N Kaur, NK Mainoo, A Levin, A Perez | | 2022 |
| Dyslipidemia Management in Persons Living with HIV A Levin | | 2020 |
